Table 3.
PCS and MCS scores of the SF-12 and SF-36 at baseline and during follow up according to indication*
| Baseline | 6 months | 12 months | Change† | SRM | |
| Myocardial infarction | |||||
| PCS-12 (n = 637) | 46 (10) | 43 (10) | 44 (10) | −1.9 (11) | −0.18 |
| PCS-36 (n = 673) | 46 (10) | 44 (11) | 45 (10) | −1.7 (11) | −0.15 |
| MCS-12 (n = 637) | 50 (11) | 49 (11) | 49 (11) | −0.5 (11) | −0.05 |
| MCS-36 (n = 673) | 49 (11) | 48 (11) | 48 (11) | −0.5 (11) | −0.04 |
| CABG | |||||
| PCS-12 (n = 391) | 35 (11) | 42 (10) | 43 (10) | 7.7 (12) | 0.63 |
| PCS-36 (n = 412) | 36 (11) | 42 (10) | 43 (11) | 7.3 (12) | 0.60 |
| MCS-12 (n = 391) | 46 (12) | 51 (10) | 51 (10) | 4.8 (13) | 0.37 |
| MCS-36 (n = 412) | 45 (12) | 50 (11) | 50 (11) | 4.3 (13) | 0.33 |
| PTCA | |||||
| PCS-12 (n = 64) | 35 (11) | 39 (10) | 39 (11) | 4.6 (10) | 0.48 |
| PCS-36 (n = 69) | 36 (11) | 40 (10) | 41 (11) | 4.2 (9) | 0.47 |
| MCS-12 (n = 64) | 44 (11) | 47 (11) | 48 (10) | 3.5 (12) | 0.29 |
| MCS-36 (n = 69) | 43 (12) | 46 (11) | 46 (11) | 2.9 (12) | 0.25 |
Data are mean (SD).
*Numbers refer to patients with complete data at baseline and follow up; †change between 12 months and baseline. Values may not add up due to rounding.
CABG, coronary artery bypass grafting; PTCA, percutaneous transluminal coronary angioplasty; SRM, standardised response mean.